All Modules

Treatment of Diabetes: Pharmacotherapy (Complementary and Alternative Medicine)

Laura Shane-McWhorter, PharmD, BCPS, FASCP, CDE, BC-ADM
Professor, University of Utah College of Pharmacy

  1. Complementary and alternative medicines commonly used in diabetes
  2. Complementary and alternative medicine
    1. Definition,
    2. Role in pharmacotherapy
    3. References

Key words: Definition, Role in Pharmacotherapy, References

Complications

R. Keith Campbell, RPh, FASHP, CDE
Distinguished Professor of Pharmacy, Washington State University

  1. Impact of complications of diabetes
  2. Complications
    1. Physiological mechanisms
    2. Impacts
    3. Medication treatment options

Key words: Impacts, Physiological, Treatment Options

Cultural Competence: Hispanic/Latino Patients with Diabetes

Gladys Garcia, PharmD
Assistant Professor of Clinical Pharmacy, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia
Francisco Javier Jimenez, RPh, PharmD, BCPS, CDE
Associate Professor, University of Puerto Rico School of Pharmacy Clinical Pharmacist, Farmacia San Jose, Puerto Rico
Krista Salazar, PharmD, PhC
Assistant Professor, Pharmacy Clinician Educator, University of New Mexico

  1. Health care professionals improve care for patients of diverse racial and ethnic groups with diabetes
  2. Cultural Competence: Hispanic/Latino Patients with Diabetes
    1. Hispanic Population
    2. Cultural barriers
    3. Cultural competence

Key words: Hispanic Population, Barriers, Competence

Educational Goal Setting, Lifelong Learning, Survival Skills, Visually Impaired

Linda Siminerio, RN, PhD, CDE
Executive Director, University of Pittsburgh Diabetes Institute
Assistant Professor, Division of Endocrinology, University of Pittsburgh School of Medicine Assistant Professor, University of Pittsburgh School of Nursing

  1. Importance of diabetes self-management education, role in helping patients to maintain good glycemic control
  2. Importance of diabetes self-management education
    1. Goal setting
    2. Life stages
    3. Adult education vs. child learners
  3. Educational Goal Setting, Lifelong Learning, Survival Skills, Visually Impaired

Key words: Goal Setting, Behavior Change, Life Stages

Pharmacist Practice in Changing Models

Maria A. Osborne, PharmD, BCACP, CDE
Clinical Pharmacist, Family Practice, UPMC St. Margaret

  1. New models of primary care and role of pharmacist into the motivation and quality measures of these new models
  2. Pharmacist Practice in Changing Models
    1. New healthcare models
    2. ACO vs PCMH
    3. Quality metrics

Key words: Models, ACO, PCMH, Metrics

The Pharmacist's Role in Management of the Patient with Diabetes

Jerry Meece, RPh, FAA, CDE
Owner, Director of Clinical Services, Plaza Pharmacy and Wellness Center

  1. Pharmacists role in management of diabetes patients
    1. Diabetes care in US
    2. Framework
    3. Diabetes care program
  2. Describe the many roles that pharmacists may play in the management of patients with diabetes

Key words: Impact, Care Program, Framework

Psychological Issues

William Polonsky, PhD, CDE
President and Founder, Behavioral Diabetes Institute; Assistant Clinical Professor in Psychiatry, University of California, San Diego

  1. Psychological issues facing diabetes patients and identify techniques to address those issues
  2. Psychological
    1. Influence
    2. Self-Management behaviors
    3. Self-Care Plans

Key words: Self-Care, Behaviors, Issues

Definition and Pathophysiology

Curtis Triplett, PharmD
Associate Professor, Department of Medicine, Division of Diabetes
University of Texas Health Science Center at San Antonio
Research PharmD, Texas Diabetes Institute

  1. Define Diabetes Mellitus
  2. Identify and explain the eight underlying pathophysiological abnormalities sited for type 2 diabetes
  3. Distinguish the mechanisms by which glucose is tightly regulated in normal healthy people

Key words: Definition, Metabolism, Hepatic Glucose

Insulin Therapy

Scott Drab, PharmD, CDE, BC-ADM
Associate Professor of Pharmacy & Therapeutics and Director of University Diabetes Care Associates
Nicole Pezzino, PharmD
Assistant Professor, Pharmacy Practice, Wilkes University

  1. Characteristic of Healthy Basal Insulin secretion
  2. Insulin Sources
  3. Bolus Rapid Active Inhaled Insulin

Key words: Basal Bolus Concepts, Glargine, Detemir

Insulin Devices

James Bennett, RPh, FACA, CDE
James Bennett Apothecary Powered by Walgreens, Director EMPOWER Diabetes Education Program and MTM specialist

  1. Identify perceived barriers to initiating insulin therapy and assist patients in overcoming them
  2. Compare and contrast various insulin delivery strategies and assist patients in their choices
  3. Discuss the various types of injection aids and insertion aids that might help a patient who has special needs

Key words: Devices, Barriers, Pen, Injection

Insulin Dosing

Scott Drab, PharmD, CDE, BC-ADM
Associate Professor of Pharmacy & Therapeutics and Director of University Diabetes Care Associates

  1. Determine Between Intensive Insulin Therapy or Conventional Insulin
  2. Develop Dosing Schedule
  3. Adjustments to Basil Insulin Dose

Key words: Insulin Dosing, Special Issues, Therapeutic

Non-Insulin Injectable Agents

Scott Drab, PharmD, CDE, BC-ADM
Associate Professor of Pharmacy & Therapeutics and Director of University Diabetes Care Associates
Nicole Pezzino, PharmD
Assistant Professor, Pharmacy Practice, Wilkes University

  1. Effects of Exenatide on Fasting Plasma Glucose and Insulin in Type 2 Diabetes
  2. Exenatide: Clinical Pharmacology
  3. Dosage and Administration

Key words: Dosage and Administration, Extended Release, Deficiency

Oral Pharmacotherapy

Scott Drab, PharmD, CDE, BC-ADM
Associate Professor of Pharmacy & Therapeutics and Director of University Diabetes Care Associates
Nicole Pezzino, PharmD
Assistant Professor, Pharmacy Practice, Wilkes University

  1. Pharmacologic Treatment of Type 2 Diabetes
  2. Management of Hyperglycemia in Type 2 Diabetes: A patient centered approach

Key words: Oral Agents, Injectable Agents, Biguanides

Comprehensive Approach to the Management of Diabetes

Guillermo Umpierrez, MD
Professor of Medicine in the Division of Endocrinology and Metabolism, Emory University and Chief of diabetes and endocrinology at Grady Memorial Hospital

  1. Pathophysiology of type 2 diabetes
  2. Therapeutics of type 2 diabetes
  3. Weight loss interventions

Key words: Complications, Pathogenesis, Advantages vs Disadvantages

Medication Safety

Matthew Grissinger, RPh, FISMP, FASCP
Institute for Safe Medication Practices – Director Error Reporting Programs

  1. Describe system-based causes of medication errors associated with the use of insulin
  2. Analyze examples of latent failures in each phase of the medication use process that contribute to errors with the use of insulin

Key words: Errors, Cross Contamination, Patient Education